Weibrich Gernot, Streckbein Philipp, Krummenauer Frank, Wagner Wilfried
Department of Prosthetic Dentistry, Johannes Gutenberg University, Mainz, Germany.
Int J Oral Maxillofac Implants. 2006 Sep-Oct;21(5):795-800.
In 1998, a modification of the macrostructure of the Frialit-2 implant in the cervical region was introduced to stabilize peri-implant bone. Limited data are available on the clinical effect of this modification. Therefore, the soft-tissue situation, marginal bone loss, and implant failure rate were analyzed after 4 years of clinical experience with the modified Frialit-2 Synchro implant.
From 1998 to 2001, 190 cervically modified implants were placed and documented prospectively in 58 patients. Of these implants, 147 were placed in original jaw bone, 22 in areas augmented with local osteoplasty, and 21 in iliac crest bone graft. The main indications for implantation were an atrophic edentulous alveolar crest (n = 99) and support for a partial denture (n = 39), followed by restoration of a shortened dental arch (n = 28) and single tooth replacement (n = 24). In a special clinical examination, 39 patients with 134 implants were investigated.
The average in situ time of the 134 implants was 23.1 months. Failing osseointegration (n = 10), peri-implantitis (n = 1), and tumor resection (n = 3) in 8 patients resulted in the failure of 14 of 190 implants (7.4%). One patient with 4 implants died (2.1%). Currently, 3 patients with a total of 6 implants have been lost to follow-up (3.1%), and 166 implants remain in situ (87.4% of 190).
Using different implant success criteria, success rates of 88.8% and 82.8% were calculated.
Based on the results, the Frialit-2 Synchro implant appears to be a useful implant system for the indications analyzed.
1998年,Frialit-2种植体颈部区域的宏观结构进行了改良,以稳定种植体周围骨组织。关于这一改良的临床效果,现有数据有限。因此,在对改良后的Frialit-2 Synchro种植体进行4年临床应用后,分析了软组织情况、边缘骨吸收及种植体失败率。
1998年至2001年,对58例患者前瞻性地植入了190枚颈部改良种植体并进行记录。其中,147枚植入原颌骨,22枚植入经局部骨成形术增强的区域,21枚植入髂嵴骨移植区。植入的主要适应证为萎缩性无牙牙槽嵴(n = 99)和局部义齿支持(n = 39),其次为短牙弓修复(n = 28)和单颗牙替换(n = 24)。在一项特殊临床检查中,对39例患者的134枚种植体进行了研究。
134枚种植体的平均在位时间为23.1个月。8例患者中种植体骨结合失败(n = 10)、种植体周围炎(n = 1)及肿瘤切除(n = 3)导致190枚种植体中的14枚失败(7.4%)。1例植入4枚种植体的患者死亡(2.1%)。目前,共有6枚种植体的3例患者失访(3.1%),166枚种植体仍在位(190枚的87.4%)。
采用不同的种植体成功标准,计算出成功率分别为88.8%和82.8%。
基于这些结果,Frialit-2 Synchro种植体对于所分析的适应证似乎是一种有用的种植系统。